All News
Relapsing polychondritis RP is a systemic condition and not just inflammation in the ears 👂 Ferrara M #ACR23 @RheumNow https://t.co/BXvyWYMYa0
Dr. Antoni Chan ( View Tweet)
Outcome scores for TTP, using the PLASMIC score to decide on treatment for TTP, Ortel T, #ACR23 @RheumNow https://t.co/Gbn7ZqkH5Y
Dr. Antoni Chan ( View Tweet)
The role of caplacizumab in the treatment of TTP, Ortel T #ACR23 @RheumNow https://t.co/VAWOlNBRuh
Dr. Antoni Chan ( View Tweet)
Recombinant ADAMTS13 therapy just @US_FDA approved - will save these patients recurrent plasma infusions (every couple of weeks for months), a big win.
https://t.co/lKdWTMp2oc
#ACR23 Review Course @RheumNow https://t.co/2NMbJvseiA
David Liew drdavidliew ( View Tweet)
Summary of recommendations for thrombotic microangiopathy (TMA), think of ADAMTS13, Ortel T, #ACR23 @RheumNow https://t.co/eSaocPSLUH
Dr. Antoni Chan ( View Tweet)
Bummed to miss sunny San Diego but still excited to join #ACR23 @RheumNow
Time to get some learnin' on!
Informative review on the role of systemic treatments and the rheumatologists role in ocular inflammation. https://t.co/0nFDEZHfGW
Robert B Chao, MD ( View Tweet)
Did you know about Tubulointerstitial nephritis uveitis (TINU) syndrome? Usually younger pts; uveitis may not be concurrent with the TIN. Risks: NSAID/abx, infx, genetics. Nice systematic review of this entity (link below). #boardquestion @rheumnow #ACR23 https://t.co/HDqLDHyGM6
TheDaoIndex KDAO2011 ( View Tweet)
Systemic inflammatory conditions related to scleritis #ACR23 @RheumNow https://t.co/qc6szUnOUl
Dr. Antoni Chan ( View Tweet)
Keeping the eyes 👀 on the target. Early start to the day with the ACR review course on the eye 👁️ in rheumatic disease. Causes of uveitis #ACR23 @RheumNow https://t.co/g5y5Vs01RX
Dr. Antoni Chan ( View Tweet)
ID testing for pts with inflammatory eye disease: syphilis, TB, Lyme (where appropriate). Low yield is toxoplasma, toxocara and viral dz - Dr L Kopplin #ACRReview
@RheumNow #ACR23 https://t.co/UyQ8Bc2cEy
TheDaoIndex KDAO2011 ( View Tweet)
Super fun meeting with fellows for the annual FIT session yesterday!
Thanks to everyone who came to my table for the expensive FedEx'ed handouts 😂
Here's a link to a PDF & pics if anyone is interested in the handout!
@RheumNow #ACR23
https://t.co/kh7sOh2BWj https://t.co/DoEZzHSaAp
Mike Putman EBRheum ( View Tweet)
We have a massive rheumatology workforce shortage issue.
Can chatbots help screen/triage patients for rheum diseases?
Enormous potential from this SG🇸🇬 pilot, getting pts to the right care quicker. We need to own & drive this!
@Ninzywong https://t.co/k4m4oQbA5P
#ACR23 @RheumNow https://t.co/RzFnkoez1E
David Liew drdavidliew ( View Tweet)
"Reproductive right is a global issue"- @CuoghiE suggests what Rheums can do:
👉Advocate for legislation to help pts
👉Integrate family planning
👉Prescribe emergency contraception
👉Provide education about reproductive health
#GlobalSummit @ACRheum @RheumNow https://t.co/jLHpzJT2wf
TheDaoIndex KDAO2011 ( View Tweet)
Dr. del Carmen Zamora-Medina listed several reasons why rheum patients may seek #abortion: teratogenic meds, comorbidities, high disease activity, increased APOs, &women focused reasons. #ACR23 @GlobalSummit #ReproductiveRights @Rheumnow https://t.co/CaH9GVfVvY
TheDaoIndex KDAO2011 ( View Tweet)
Such contrast to the US!
Mexico’s legislature has de-criminalized abortion, making legal and safe abortions avail to rheum pts #ACR23 #GlobalSummit @Rheumnow @CuoghiE https://t.co/xAezGyav0E
TheDaoIndex KDAO2011 ( View Tweet)
There are lots of reasons why First Nations people might have difficulties with rheumatology care (especially those in remote communities).
Population realities
Healthcare access
Medication access
All have a very real impact on the quality of care we deliver.
#ACR23 @RheumNow https://t.co/qDBsQRWjk9
David Liew drdavidliew ( View Tweet)
What did they do in Canada to improve the care for their patients of Indigenous background?
Practical but strategic approach to healthcare service improvement - that lead to real benefits.
#ACR23 @RheumNow https://t.co/VlGW3KBFCj
David Liew drdavidliew ( View Tweet)
Dr. Iyer - factors driving inequity in the access of essential medicines esp. in low to middle-income countries:
💠availability
💠affordability
💠accessibility
💠acceptability
#ACR23 @RheumNow @rheumarhyme https://t.co/eIvOAjg31H
sheila ( View Tweet)
Inequities in Medical Care Delivery:
👉>80% of people live in low/middle income places
👉2 billion people are unable to access meds and healthcare services
👉Availability, accessibility, affordability, acceptability are the 4 barriers
Dr. J Iyer #ACR23 @RheumNow #GlobalSummit https://t.co/u21NTAYBpY
TheDaoIndex KDAO2011 ( View Tweet)
Big Pharma – Pay attention! When developing new therapeutics, consider delivery, cost, climate sensitivity and sustainability #GlobalSummit @ACRheum @rheumnow #ACR23 https://t.co/ThqnTI3SNm
TheDaoIndex KDAO2011 ( View Tweet)
